Stem Cell Study in Osteoarthritis of the Knee and Hip Joints
A legfontosabb adatok
- Ki végzi
- Grigory Karmy
- Hol
- Brampton (Kanada)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Fázis
- 2. fázis
- Résztvevők
- 400 fő, tervezett
- Kezdés
- 2022. aug. 23.
- Várható befejezés
- 2028. aug. 8.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Bone Marrow Aspirate, Lipoaspirate Concentrate
- A regiszteradat frissítve
- 2026. augusztus 25.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults living in Canada with painful knee or hip osteoarthritis (joint wear). It compares one joint injection of cells taken from the person's own fat tissue with one taken from their own bone marrow.
- Életkor
- 18 to 95 years
- Nem
- Men and women
- A betegség stádiuma
- Knee or hip osteoarthritis with symptoms for at least 12 weeks, seen on an X-ray within 1 year (Kellgren-Lawrence Grade I to IV). Average pain score of 4-9 on the NRS scale (moderate to severe pain). BMI ≤ 50 kg/m2.
- Korábbi kezelés
- Pain must have lasted more than 12 weeks after trying two or more of these: pain pills or supplements, physiotherapy, acupuncture, bracing, cortisone, hyaluronic acid, dextrose or platelet-rich plasma injections. No cortisone or dextrose joint injections in the last 3 months, and no hyaluronic acid or PRP joint injections in the last 6 months.
A részvétel fő kizáró okai
- Pregnant or planning pregnancy, or not using effective birth control when able to become pregnant
- Cancer within 5 years, except basal cell carcinoma
- Joint replacement, rods or screws in the joint to be injected, or surgery on it within 6 months or planned
- Autoimmune disease such as lupus or rheumatoid arthritis, or a blood clotting disorder
- Medicines that weaken the immune system or chemotherapy within 3 months
A regiszter feltételei, szó szerint
Mind a 28 feltétel megnézéseKevesebb
Ki vehet részt
- Male or female, aged 18 to 95 years old
- Residents of Canada
- Written informed consent to participate in the study
- Willingness and ability to comply with the study procedures and phone visit schedules and ability to follow verbal and written instruction
- The NRS for at least 5 daily measures will be used to calculate the average score. An average NRS pain score 4-9 (moderate to severe pain)
- Diagnosis of symptomatic knee or hip osteoarthritis for at least 12 weeks prior to screening based on an X-ray performed within 1 year prior to screening period
- Radiographic evidence of OA of the index knee or hip (Kellgren-Lawrence Grade I to IV) within 1 year prior to screening or during the screening period
- Failed conservative treatment for more than 12 weeks before the screening, meaning that pain persists for more than 12 weeks after the patient tried two or more of the following medication or interventions in that period; oral analgesics, including over-the-counter medications and supplements,; physiotherapy; acupuncture; bracing; cortisone injections,; hyaluronic acid injections,; dextrose injections (prolotherapy); platelet-rich plasma injections
- Women of childbearing potential must use an effective method of contraception from 14 days prior to baseline visit to 360 days after intervention. Effective birth control considered for this trial are total abstinence; consistent use of birth control pills; injectable birth control methods; intrauterine device placement; and tubal ligation or male partner with vasectomy; diaphragm with contraceptive jelly or condom with contraceptive foam.This does not apply to male and postmenopausal women
- Body mass index (BMI) ≤ 50 kg/m2
Ki nem vehet részt
- Prior arthroscopic or open surgery of the index joint within 6 months prior to screening
- Planned arthroscopic or open surgery of the index joint during study period
- Use of systemic immunosuppressives, immunomodulators or chemotherapeutic agents within 3 months prior to baseline visit
- Subjects participating in a study of an experimental drug or medical device within 30 days of study entry
- History of malignancy except for the diagnosis of basal cell carcinoma, within 5 years prior to pre-screening
- History of autoimmune diseases including lupus and rheumatoid arthritis
- Know hypersensitivity to lidocaine, epinephrine or heparin
- History of coagulopathy
- Subjects with cutaneous infection at the lipoaspirate or bone marrow aspirate site and/or in the area of the injection at baseline visit
- Any medical condition the qualified investigator believes makes the patient unsuitable for the study
- Intra-articular injections in the index joint within 3 months prior to screening for corticosteroids or dextrose injections, and within 6 months prior to screening for hyaluronic acid or platelet-rich plasma (PRP) injections
- Subjects with hemoglobin less than 10 g/L
- Subjects with platelet count less than 155x109/L
- Subjects using warfarin before the screening, with an INR above 3
- Women who are pregnant or planning to become pregnant during the trial period
- Women of childbearing potential (not surgically sterile or post-menopausal for at least one year) not using a highly effective method of contraception such as total abstinence; consistent use of birth control pills; injectable birth control methods; intrauterine device placement; and tubal ligation or male partner with vasectomy; diaphragm with contraceptive jelly or condom with contraceptive foam
- Presence of retained rods or screws or insertion or joint replacement in the joint to be injected
- Fever (forehead temperature above 38.0 centigrade) at baseline visit
Nézd meg, megfelelhetsz-e
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 95 év között vagy?
Helyszínek itt: Kanada
- Karmy ClinicBrampton, KanadaContact: Grigory Karmy, MDRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The purpose of this trial is to compare the effect of a single intra-articular injection of Lipoaspirate Concentrate vs Bone Marrow Aspirate on pain reduction and functional improvement in the treatment of the knee and hip OA.
A vizsgálat 2 csoportja
- Knee arm randomized to Lipoaspirate Concentrate and Bone Marrow AspirateMár használt kezelés, összehasonlításként
The Subjects will be randomized to one of the treatment groups separately for the knee and hip arms of the study. Group A will receive a single intra-articular injection with lipoaspirate concentrate to the knee and Group B will receive a single intra-articular injection with bone marrow aspirate concentrate.
Kezelés: Bone Marrow Aspirate, Lipoaspirate Concentrate
- Hip Arm randomized to Lipoaspirate Concentrate and Bone Marrow AspirateMár használt kezelés, összehasonlításként
The subjects will be randomized to one of the treatment groups separately for the knee and hip arms of the study. Groups C will receive a single intra-articular injection with lipoaspirate concentrate to the hip and Group D will receive a single intra-articular injection with bone marrow aspirate.
Kezelés: Bone Marrow Aspirate, Lipoaspirate Concentrate
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Phase 2, Randomized Study to Compare Bone Marrow Aspirate Versus Lipoaspirate Concentrate Autologous Cell Therapy for the Treatment of the Knee and Hip Osteoarthritis in Adults
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Illeszkedési kérdések
- Forrás: NCT05507099: ki vehet részt
- A regiszteradat frissítve
- 2026. augusztus 25.